Maxim Group Doesn't See Anything Nefarious at Anavex (AVXL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Anavex Life Sciences (AVXL) Slammed After Disclosing SEC Subpoena and Formal Investigation
December 29, 2015 8:44 AM ESTAnavex Life Sciences (NASDAQ: AVXL) is under heavy pressure (-21%) early after disclosing an SEC subpoena and formal investigation in its 10-K. The company believes the subpoena and investigation relate to the recent unusual activity in the market for the Companys... More
